Switch from IL-5 to IL-5-Receptor α Antibody Treatment in Severe Eosinophilic Asthma

BACKGROUND: Anti-IL-5 antibodies represent an established therapy for severe eosinophilic asthma (SEA), but some patients show inadequate response. The objective of this study was to assess the effects of a switch to anti-IL-5Rα therapy in patients with inadequate response to anti-IL-5 therapy. METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Drick, Nora, Milger, Katrin, Seeliger, Benjamin, Fuge, Jan, Korn, Stephanie, Buhl, Roland, Schuhmann, Maren, Herth, Felix, Kendziora, Benjamin, Behr, Juergen, Kneidinger, Nikolaus, Bergmann, Karl-Christian, Taube, Christian, Welte, Tobias, Suhling, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667509/
https://www.ncbi.nlm.nih.gov/pubmed/33204117
http://dx.doi.org/10.2147/JAA.S270298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667509/
https://www.ncbi.nlm.nih.gov/pubmed/33204117
http://dx.doi.org/10.2147/JAA.S270298

Ejemplares similares